Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19

While COVID-19, the disease driven by SARS-CoV-2 has ignited interest in the host immune response to this infection, it has also highlighted the lack of treatment options for the damaging inflammatory responses driven by pathogens that precipitate the acute respiratory distress syndrome (ARDS). With...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Ther
Main Authors: Gilroy, Derek W., De Maeyer, Roel P.H., Tepper, Mark, O’Brien, Alastair, Uddin, Mohib, Chen, Judy, Goldstein, Daniel R., Akbar, Arne N.
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier Inc. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657264/
https://ncbi.nlm.nih.gov/pubmed/33188794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2020.107745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados